SEI Investments
MDLN

SEI Investments’s Medline Inc MDLN Stock Holding History

SEI Investments’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.1M Buy
1,327,179
+504,713
+61% +$22.3M 0.05% 374
2025
Q4 		$34.5M Buy
+822,466
New +$34.7M 0.03% 522

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

SEI Investments's MDLN Position: Q1 2026 in Review

SEI Investments increased its Medline Inc (MDLN) stake by 61% in Q1 2026, buying an estimated $22.3M and bringing the position to 1,327,179 shares worth $59.1M. The position accounts for 0.05% of the portfolio, ranked #374.

SEI Investments first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • SEI Investments held 1,327,179 shares of Medline Inc worth $59.1M as of Q1 2026.
  • SEI Investments bought 504,713 Medline Inc shares in Q1 2026, an estimated $22.3M.
  • Medline Inc made up 0.05% of SEI Investments's portfolio in Q1 2026, its #374 holding.
  • SEI Investments first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.